Alternatively spliced fibronectin extra domain A is required for hemangiogenic recovery upon bone marrow chemotherapy

Haematologica. 2018 Feb;103(2):e42-e45. doi: 10.3324/haematol.2017.173070. Epub 2017 Nov 16.

Alessandro Malara^{1

2}, Cristian Gruppi¹, Giuseppe Celesti³, Vittorio Abbonante^{1

2}, Gianluca Viarengo⁴, Luigi Laghi³, Luigi De Marco^{5

6}, Andrés F Muro⁷, Alessandra Balduini^{8

2

9}

¹ Department of Molecular Medicine, University of Pavia, Italy.
² Laboratory of Biotechnology, IRCCS San Matteo Foundation, Pavia, Italy.
³ Laboratory of Molecular Gastroenterology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
⁴ Immunohaematology and Transfusion Service, Apheresis and Cell Therapy Unit, IRCCS San Matteo Foundation, Pavia, Italy.
⁵ Department of Translational Research, National Cancer Center (IRCCS CRO), Aviano, Italy.
⁶ Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA.
⁷ The International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
⁸ Department of Molecular Medicine, University of Pavia, Italy [email protected].
⁹ Department of Biomedical Engineering, Tufts University, Medford, MA, USA.

No abstract available

Publication types